Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
1,24 USD | +14,81% |
|
+46,57% | +57,96% |
Attività
Numero di dipendenti: 18
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Alon Ben-Noon
FOU | Founder | 45 | 13/02/17 |
Or Eisenberg
DFI | Director of Finance/CFO | 43 | 01/06/21 |
Hagit Binder
COO | Chief Operating Officer | - | - |
Shiran Zimri
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/20 |
Irit Shefer
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/22 |
Ferenc Tracik
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/12/21 |
Chief Tech/Sci/R&D Officer | 63 | - | |
Diana Shtossel
LAW | General Counsel | - | 01/01/22 |
Corporate Officer/Principal | - | 01/03/22 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Director/Board Member | 56 | 21/12/21 | |
Chairman | 67 | 01/10/21 | |
Cary Claiborne
BRD | Director/Board Member | 64 | 01/12/21 |
Director/Board Member | 49 | 01/01/22 | |
Alon Ben-Noon
FOU | Founder | 45 | 13/02/17 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 18 037 006 | 13 085 886 ( 72,55 %) | 0 | 72,55 % |
Coordinate società
Neurosense Therapeutics Ltd.
11 HaMenofim Street Building B
46725, Herzliya
+
http://www.neurosense-tx.com![Indirizzo NeuroSense Therapeutics Ltd.(NRSN)](https://cdn.zonebourse.com/static/address/130483704.png)
Settore
![Consenso](/images/consensus_flch.gif)
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
+57,96% | 22,37 Mln | |
+16,44% | 122 Mrd | |
+18,94% | 113 Mrd | |
+18,89% | 26,22 Mrd | |
-25,37% | 19,01 Mrd | |
-20,14% | 15,71 Mrd | |
-20,20% | 15,22 Mrd | |
-47,37% | 14,72 Mrd | |
+59,91% | 14,58 Mrd | |
+4,35% | 13,84 Mrd |
- Borsa valori
- Azioni
- Azione NRSN
- Società NeuroSense Therapeutics Ltd.